Drug Manufacturers - Specialty & Generic | Healthcare
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Limited.
Market Cap
1185742061568
Current Price
3503.5
52 Week Range
2886.45 - 3590.7
Previous Close
3524.0
Open
3510.0
Sector
Healthcare
Address
Torrent House, Off Ashram Road, Ahmedabad, 380009, India
Phone
+91-79265-99000
Fax
+91-79265-82100
Website
https://www.torrentpharma.com
Day Low
3468.0
Day High
3527.5
Dividend Yield
0.91
PE Ratio
62.140827
Earnings Per Share
56.38
Beta
0.18
EBITDA
36758200320
Book Value
224.281
EPS
73.64357
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Samir Uttamlal Mehta B.Com., MBA | Executive Chairman & MD | 61 | 1963 |
Mr. Jinesh Shah B.Sc., MBA | Chief Operating Officer | 47 | 1977 |
Mr. Aman Mehta | Whole-Time Director | - | - |
Mr. Sudhir Menon CA, CWA | Executive Director of Finance & CFO | 52 | 1972 |
Mr. Chintan M. Trivedi | Company Secretary & Compliance Officer | - | - |
Mr. Jaydip Bhatt | Vice President of Human Resource | 71 | 1953 |
Mr. Abdullah Salam Said Al Abri | Chief Customer Service Officer | - | - |
Mr. Sanjay Gupta | President and CEO of Torrent Pharma USA | - | - |
Mr. Ashish Hajarnish M.Pharm | Executive Director of Operations | 56 | 1968 |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.